Other Species / Isoforms
  ARGLU1 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

  HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S12-p
RSRSSSRsKHTKSSK
0 1
ARGLU1 (human) RSRSSSRsKHTKSSK S12-p
ARGLU1 iso2 (human) RSRSSSRSKHTKSSK S12
ARGLU1 (mouse) RSRSSSRSKHTKSSK S12
ARGLU1 (rat) RSRSSSRSKHTKSSK S12
S25-p
SKHNKKRsRsRsRsR
0 1
ARGLU1 (human) SKHNKKRsRsRsRsR S25-p
ARGLU1 iso2 (human) SKHNKKRSRSRSRSR S25
ARGLU1 (mouse) SKHNKKRSRSRSRSR S25
ARGLU1 (rat) SKHNKKRSRSRSRSR S25
S27-p
HNKKRsRsRsRsRDK
0 1
ARGLU1 (human) HNKKRsRsRsRsRDK S27-p
ARGLU1 iso2 (human) HNKKRSRSRSRSRDK S27
ARGLU1 (mouse) HNKKRSRSRSRSRDK S27
ARGLU1 (rat) HNKKRSRSRSRSRDK S27
S29-p
KKRsRsRsRsRDKER
0 1
ARGLU1 (human) KKRsRsRsRsRDKER S29-p
ARGLU1 iso2 (human) KKRSRSRSRSRDKER S29
ARGLU1 (mouse) KKRSRSRSRSRDKER S29
ARGLU1 (rat) KKRSRSRSRSRDKER S29
S31-p
RsRsRsRsRDKERVR
0 1
ARGLU1 (human) RsRsRsRsRDKERVR S31-p
ARGLU1 iso2 (human) RSRSRSRSRDKERVR S31
ARGLU1 (mouse) RSRSRSRSRDKERVR S31
ARGLU1 (rat) RSRSRSRSRDKERVR S31
S46-p
KRSKSREsKRNRRRE
0 1
ARGLU1 (human) KRSKSREsKRNRRRE S46-p
ARGLU1 iso2 (human) KRSKSRESKRNRRRE S46
ARGLU1 (mouse) KRSKSRESKRNRRRE S46
ARGLU1 (rat) KRSKSRESKRNRRRE S46
S54-p
KRNRRREsRsRsRst
Upstream
0 2
Treatment
  • nocodazole
ARGLU1 (human) KRNRRREsRsRsRst S54-p
ARGLU1 iso2 (human) KRNRRRESRSRSRST S54
ARGLU1 (mouse) KRNRRRESRsRsRsT S54
ARGLU1 (rat) KRNRRRESRSRsRST S54
S56-p
NRRREsRsRsRstNT
Upstream
0 9
Treatment
  • nocodazole
ARGLU1 (human) NRRREsRsRsRstNT S56-p
ARGLU1 iso2 (human) NRRRESRSRSRSTNT S56
ARGLU1 (mouse) NRRRESRsRsRsTNA S56-p
ARGLU1 (rat) NRRRESRSRsRSTNA S56
S58-p
RREsRsRsRstNTAV
0 15
ARGLU1 (human) RREsRsRsRstNTAV S58-p
ARGLU1 iso2 (human) RRESRSRSRSTNTAV S58
ARGLU1 (mouse) RRESRsRsRsTNAAA S58-p
ARGLU1 (rat) RRESRSRsRSTNAAA S58-p
S60-p
EsRsRsRstNTAVSR
0 13
ARGLU1 (human) EsRsRsRstNTAVSR S60-p
ARGLU1 iso2 (human) ESRSRSRSTNTAVSR S60
ARGLU1 (mouse) ESRsRsRsTNAAAsR S60-p
ARGLU1 (rat) ESRSRsRSTNAAASR S60
T61-p
sRsRsRstNTAVSRR
0 2
ARGLU1 (human) sRsRsRstNTAVSRR T61-p
ARGLU1 iso2 (human) SRSRSRSTNTAVSRR T61
ARGLU1 (mouse) SRsRsRsTNAAAsRR T61
ARGLU1 (rat) SRSRsRSTNAAASRR T61
S66
RstNTAVSRRERDRE
0 1
ARGLU1 (human) RstNTAVSRRERDRE S66
ARGLU1 iso2 (human) RSTNTAVSRRERDRE S66
ARGLU1 (mouse) RsTNAAAsRRERERA S66-p
ARGLU1 (rat) RSTNAAASRRERERA S66
S76-p
ERDRERAssPPDRID
0 18
ARGLU1 (human) ERDRERAssPPDRID S76-p
ARGLU1 iso2 (human) ERDRERASSPPDRID S76
ARGLU1 (mouse) RRERERAssPPDRID S74-p
ARGLU1 (rat) RRERERASsPPDRID S74
S77-p
RDRERAssPPDRIDI
Upstream
0 104
Treatment
  • nocodazole
  • quinalizarin
ARGLU1 (human) RDRERAssPPDRIDI S77-p
ARGLU1 iso2 (human) RDRERASSPPDRIDI S77
ARGLU1 (mouse) RERERAssPPDRIDI S75-p
ARGLU1 (rat) RERERASsPPDRIDI S75-p
S94-p
RTVSKRSsLDEKQKR
Upstream
0 6
Treatment
  • nocodazole
ARGLU1 (human) RTVSKRSsLDEKQKR S94-p
ARGLU1 iso2 (human) RTVSKRSSLDEKQKR S94
ARGLU1 (mouse) RTVSKRSsLDEKQKR S92-p
ARGLU1 (rat) RTVSKRSSLDEKQKR S92
K124-ub
RQQEIEEkLIEEETA
0 1
ARGLU1 (human) RQQEIEEkLIEEETA K124-ub
ARGLU1 iso2 (human) RQQEIEEKLIEEETA K124
ARGLU1 (mouse) RQQEIEEKLIEEETA K122
ARGLU1 (rat) RQQEIEEKLIEEETA K122
K140-ub
RVEELVAkRVEEELE
0 1
ARGLU1 (human) RVEELVAkRVEEELE K140-ub
ARGLU1 iso2 (human) RVEELVAKRVEEELE K140
ARGLU1 (mouse) RVEELVAKRVEEELE K138
ARGLU1 (rat) RVEELVAKRVEEELE K138
K188-ub
QAELAAQkAREEEER
0 1
ARGLU1 (human) QAELAAQkAREEEER K188-ub
ARGLU1 iso2 (human) QAELAAQKAREVTLG K188
ARGLU1 (mouse) QAELAAQKAREEEER K186
ARGLU1 (rat) QAELAAQKAREEEER K186
R225-m1
KLAEEQLrIVEEQRK
0 1
ARGLU1 (human) KLAEEQLrIVEEQRK R225-m1
ARGLU1 iso2 (human) gap -
ARGLU1 (mouse) KLAEEQLRIVEEQRK R223
ARGLU1 (rat) KLAEEQLRIVEEQRK R223
K258
EQKIILGKGKSRPKL
0 1
ARGLU1 (human) EQKIILGKGKSRPKL K258
ARGLU1 iso2 (human) gap -
ARGLU1 (mouse) EQKIILGKGKSRPKL K256
ARGLU1 (rat) EQKIILGkGKSRPkL K256-ac
K264
GKGKSRPKLsFsLKt
0 1
ARGLU1 (human) GKGKSRPKLsFsLKt K264
ARGLU1 iso2 (human) gap -
ARGLU1 (mouse) GKGKSRPKLsFSLKT K262
ARGLU1 (rat) GkGKSRPkLSFSLKT K262-ac
S266-p
GKSRPKLsFsLKtQD
Upstream
0 15
Treatment
  • antibody
ARGLU1 (human) GKSRPKLsFsLKtQD S266-p
ARGLU1 iso2 (human) gap -
ARGLU1 (mouse) GKSRPKLsFSLKTQD S264-p
ARGLU1 (rat) GKSRPkLSFSLKTQD S264
S268-p
SRPKLsFsLKtQD__
0 5
ARGLU1 (human) SRPKLsFsLKtQD__ S268-p
ARGLU1 iso2 (human) gap -
ARGLU1 (mouse) SRPKLsFSLKTQD__ S266
ARGLU1 (rat) SRPkLSFSLKTQD__ S266
T271-p
KLsFsLKtQD_____
0 6
ARGLU1 (human) KLsFsLKtQD_____ T271-p
ARGLU1 iso2 (human) gap -
ARGLU1 (mouse) KLsFSLKTQD_____ T269
ARGLU1 (rat) kLSFSLKTQD_____ T269